These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15768333)

  • 1. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
    Sulkowski MS; Thomas DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S263-9. PubMed ID: 15768333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M; Reimer J; Meyer K; Gerlach JT; Zachoval R
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
    Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
    Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A; Treloar C; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
    Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG
    Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026.
    Werb D; Wood E; Kerr T; Hershfield N; Palmer RW; Remis RS
    Int J Drug Policy; 2011 Jan; 22(1):70-6. PubMed ID: 21051212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.